Luis Campo-Del

Murcia, MU 30120, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Metabolic buffering restricts phenotype switching in melanoma.

Metabolic buffering restricts phenotype switching in melanoma.

Journal: The EMBO journal
Published: May 28, 2025

Ex vivo engineering of phagocytic signals in breast cancer cells for a whole tumor cell-based vaccine.

Ex vivo engineering of phagocytic signals in breast cancer cells for a whole tumor cell-based vaccine.

Journal: BMC cancer
Published: February 27, 2025

MITF, TFEB, and TFE3 drive distinct adaptive gene expression programs and immune infiltration in melanoma.

MITF, TFEB, and TFE3 drive distinct adaptive gene expression programs and immune infiltration in melanoma.

Journal: Cell reports
Published: January 10, 2025

Functional specialization of MITF, TFEB and TFE3 drives radically distinct adaptive gene expression programs in melanoma.

Functional specialization of MITF, TFEB and TFE3 drives radically distinct adaptive gene expression programs in melanoma.

Journal: bioRxiv : the preprint server for biology
Published: January 07, 2025

Targeting protein methylation in pancreatic cancer cells results in KRAS signaling imbalance and inhibition of autophagy.

Targeting protein methylation in pancreatic cancer cells results in KRAS signaling imbalance and inhibition of autophagy.

Journal: Cell death & disease
Published: July 04, 2023

Editorial: Cell stress responses and metabolic reprogramming in skin diseases.

Editorial: Cell stress responses and metabolic reprogramming in skin diseases.

Journal: Frontiers in cell and developmental biology
Published: February 22, 2023

The two faces of the Integrated Stress Response in cancer progression and therapeutic strategies.

The two faces of the Integrated Stress Response in cancer progression and therapeutic strategies.

Journal: The international journal of biochemistry & cell biology
Published: June 03, 2021

Acriflavine, a Potent Inhibitor of HIF-1α, Disturbs Glucose Metabolism and Suppresses ATF4-Protective Pathways in Melanoma under Non-Hypoxic Conditions.

Acriflavine, a Potent Inhibitor of HIF-1α, Disturbs Glucose Metabolism and Suppresses ATF4-Protective Pathways in Melanoma under Non-Hypoxic Conditions.

Journal: Cancers
Published: November 30, 2020

MITF induces escape from innate immunity in melanoma.

MITF induces escape from innate immunity in melanoma.

Journal: Journal of experimental & clinical cancer research : CR
Published: October 08, 2020

PRMT1-dependent methylation of BRCA1 contributes to the epigenetic defense of breast cancer cells against ionizing radiation.

PRMT1-dependent methylation of BRCA1 contributes to the epigenetic defense of breast cancer cells against ionizing radiation.

Journal: Scientific reports
Published: March 20, 2020

BRN2 is a non-canonical melanoma tumor-suppressor.

BRN2 is a non-canonical melanoma tumor-suppressor.

Journal: Nature communications
Published: April 24, 2019

Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.

Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.

Journal: Genes & development
Published: September 19, 2016
Showing 1-12 of 21

Last Updated: 09/26/2026